Retrospective Overview of COVID-19 in Europe
Author:
Ondrejková A.1, Süli J.2, Zemanová S.1, Tomčová J.1, Korytár Ľ.1
Affiliation:
1. Department of Epizootiology , Parasitology and Protection of One′s Health 2. Department of Chemistry, Biology and Biophysics , University of Veterinary Medicine and Pharmacy in Košice , Komenského 73 , Košice , Slovakia
Abstract
Abstract
A disease of unknown origin connected with severe pneumonia was identified in Wuhan (China) in December 2019. It was named coronavirus disease 2019 (COVID-19). The disease had rapidly spread all over the world, including Europe. The World Health organization (WHO) declared the disease a pandemic. The aim of this study is to summarize and to compare objectively the epidemiological situation of COVID-19 in European countries from 15 February 2020 to 31 December 2021. Due to the significant difference in the population of individual states, all data were calculated per 1 million people (parameter/1M). Cases/1M, number of death/1 M, and % of death (case fatality rate) were compared. The actual situation on 31 December 2021 was quantified by comparing the active cases/1 M in each European country. The situation in Europe has been compared also with those on the other continents of the world, respectively on 31 December 2021. In order to monitor the development of the disease spread on the national level, the European countries were compared after division into six regions: South, West, North, Middle, Balkan and East. These data were recorded daily from 15 February to 31 December 2021.
Publisher
Walter de Gruyter GmbH
Reference22 articles.
1. 1. Cao, Y., Cai, K., Xiong, L., 2020: Coronavirus disease 2019: A new severe acute respiratory syndrome from Wuhan in China. Acta Virol., 64, 2, 245—250. DOI: 10.4149/av_2020_201. 2. 2. European Centre for Disease Prevention and Control. Population-wide Testing of SARS-CoV-2, 2020: country experiences and potential approaches in the EU/EEA and the UK Stockholm, ECDC, 2020. https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-population-wide-testing-country-experiences.pdf. Accessed January 8, 2021. 3. 3. Gámbaro, F., Behillil, S., Baidaliuk, A., Donati, F., Albert, M., Alexandru, A., et al., 2020: Introductions and early spread of SARS-CoV-2 in France, 24 January to 23 March. Euro Surveill., 25, 26, 2001200. DOI: 10.2807/1560-7917.ES.2020.25.26.2001200. 4. 4. Hassell, J. M., Begon, M., Ward, M. J., Fèvre, E. M., 2017: Urbanization and disease emergence: Dynamics at the wild-life-livestock-human interface. Trends Ecol. Evol., 32, 1, 55—67. DOI: 10.1016/j.tree.2016.09.012. 5. 5. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al., 2020: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497—506. DOI: 10.1016/S0140-6736(20)30183-5.
|
|